TREATMENT OF HYPERLIPIDEMIA IN RENAL TRANSPLANT RECIPIENTS1
- 1 February 1997
- journal article
- review article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 63 (3) , 339-345
- https://doi.org/10.1097/00007890-199702150-00002
Abstract
To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldNo abstract availablKeywords
This publication has 60 references indexed in Scilit:
- Increased low density lipoprotein oxidation in stable kidney transplant recipientsKidney International, 1996
- Lipoprotein(a) in renal diseaseAmerican Journal of Kidney Diseases, 1996
- ISCHEMIC HEART DISEASE—MAJOR CAUSE OF DEATH AND GRAFT LOSS AFTER RENAL TRANSPLANTATION IN SCANDINAVIATransplantation, 1995
- Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma concentrations after renal transplantation.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Changes in Causes of Death After Renal Transplantation, 1966 to 1987American Journal of Kidney Diseases, 1991
- Lipoprotein Levels and Post-Heparin Lipase Activities in Kidney Transplant Recipients: Ciclosporin- versus Non-Ciclosporin-Treated PatientsAmerican Journal of Nephrology, 1991
- Elevated Lipoprotein(a) Levels in Renal Transplantation and Hemodialysis PatientsAmerican Journal of Nephrology, 1991
- CHANGED COMPOSITION OF HIGH-DENSITY LIPOPROTEIN SUBCLASSES HDL2 AND HDL3 AFTER RENAL TRANSPLANTATIONTransplantation, 1988
- Risk factors for accelerated atherosclerosis in renal transplant recipientsThe American Journal of Medicine, 1988
- Lipoprotein Lipid Abnormalities in Healthy Renal Transplant Recipients: Persistence of Low HDL2 CholesterolNephron, 1987